BF-03-RM76_0.1uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=0.1uM, N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)carbamoyl]amino]benzamide, Angiogenesis Inhibitors;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways;Flt3 (FLK2/STK1) Inhibitors;FGFR3 Inhibitors targeting ABL1, BCR, FGFR3, FLT3, ABL2 (Novartis, 16085322)
|
| External Link |
https://pubchem.ncbi.nlm.nih.gov/compound/16085322
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
11 genes differentially expressed following the BF-03-RM76_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
KRTAP2-3
|
keratin associated protein 2-3
|
0.540517
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
0.540517
|
|
MT2A
|
metallothionein 2A
|
0.491751
|
|
TGM2
|
transglutaminase 2
|
0.449014
|
|
UPP1
|
uridine phosphorylase 1
|
0.233406
|
|
ZNF593
|
zinc finger protein 593
|
0.203667
|
|
GLRX
|
glutaredoxin (thioltransferase)
|
0.201033
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
TMSB4X
|
thymosin beta 4, X-linked
|
-0.542011
|
|
CPA4
|
carboxypeptidase A4
|
-0.473708
|
|
BMP4
|
bone morphogenetic protein 4
|
-0.278641
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
-0.242248
|